Biotech

All Articles

Basilea credit ratings $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job establishing brand new antifungals has actually received a significant ...

Capricor sells Europe rights to late-stage DMD treatment for $35M

.Possessing currently gathered up the U.S. civil rights to Capricor Therapeutics' late-stage Duchenn...

FDA fragments adcomm for Applied's rare disease medication

.After pushing the choice date for Applied Therapeutics' metabolic ailment medication govorestat, th...

Novo inks $600M NanoVation offer to examine hereditary medications ex-liver

.Novo Nordisk is actually proceeding its own press into genetic medications, consenting to compensat...

Innovent hyperlinks cytokine to colon cancer responses

.Innovent Biologics has actually made the scenario that its own checkpoint inhibitor-cytokine blend ...

Merck, Daiichi ADC strikes target in phase 3 lung cancer research study

.A stage 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina strengthens AI center along with collab to choose cancer aim ats

.5 months after Rakovina Therapies rotated toward artificial intelligence, the cancer-focused biotec...

Ascendis' dwarfism drug favorites in phase 3, intimidates BioMarin

.Ascendis Pharma has actually become a prospective danger to BioMarin's Voxzogo, reporting phase 3 g...

Despite ph. 3 skip, Alkeus views pathway in advance for eye ailment asset

.Though Alkeus Pharmaceuticals' dental eye ailment resource fell short to substantially minimize geo...

Kairos goes social with $6M IPO to fund tests of cancer drug

.Along with a triad of biotechs hitting the Nasdaq on Friday, it was actually effortless to miss a s...